Literature DB >> 17652295

Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial.

Douglas P Kiel1, Jay Magaziner, Sheryl Zimmerman, Linda Ball, Bruce A Barton, Kathleen M Brown, Judith P Stone, Dawn Dewkett, Stanley J Birge.   

Abstract

CONTEXT: Past studies of the efficacy of hip protectors to prevent hip fracture in nursing home residents have had conflicting results, possibly due to potential biases from clustered randomization designs and modest adherence to intervention.
OBJECTIVE: To determine whether an energy-absorbing and energy-dispersing hip protector would reduce the risk of hip fracture when worn by nursing home residents. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized controlled clinical trial in which 37 nursing homes were randomly assigned to having residents wear a 1-sided hip protector on the left or right hip. Participants were 1042 nursing home residents (mean [SD] aged 85 [7] years; 79% women) who consented and adhered to the hip protector use during a 2-week run-in period and were enrolled. Participating facilities were in greater Boston, Massachusetts, St Louis, Missouri, and Baltimore, Maryland from October 2002 to October 2004. Mean duration of participation for nursing home residents was 7.8 months. None were withdrawn because of adverse effects. INTERVENTION(S): Undergarments with a 1-sided hip protector made of a 0.32-cm outer layer of polyethylene (2.7 kg/m3) backed by a hard high-density polyethylene shield (0.95 cm) that was backed by 0.9 kg/m3 of 1.27-kg ethylene vinyl acetate foam. Each facility was visited 3 times per week to assess adherence and provide staff support. MAIN OUTCOME MEASURE: Adjudicated hip fracture occurrences on padded vs unpadded hips.
RESULTS: After a 20-month follow-up (676 person-years of observation), the study was terminated due to a lack of efficacy. The incidence rate of hip fracture on protected vs unprotected hips did not differ (3.1%; 95% confidence interval [CI], 1.8%-4.4% vs 2.5%; 95% CI, 1.3%-3.7%; P = .70). For the 334 nursing home residents with greater than 80% adherence to hip protector use, the incidence rate of hip fracture on protected vs unprotected hips did not differ (5.3%; 95% CI, 2.6%-8.8% vs 3.5%; 95% CI, 1.3%-5.7%; P = .42). Overall adherence was 73.8%.
CONCLUSIONS: In this clinical trial of an energy-absorbing/shunting hip protector conducted in US nursing homes, we were unable to detect a protective effect on the risk of hip fracture, despite good adherence to protocol. These results add to the increasing body of evidence that hip protectors, as currently designed, are not effective for preventing hip fracture among nursing home residents. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00058864.

Entities:  

Mesh:

Year:  2007        PMID: 17652295     DOI: 10.1001/jama.298.4.413

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  39 in total

1.  Discrepancies in national incidence trends for hip fracture: why does Austria have such a high incidence?

Authors:  Eva Mann; Andrea Icks; Gabriele Meyer
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

2.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

Review 3.  Emergency orthogeriatrics: concepts and therapeutic alternatives.

Authors:  Christopher R Carpenter; Michael E Stern
Journal:  Emerg Med Clin North Am       Date:  2010-11       Impact factor: 2.264

Review 4.  Shifting the focus in fracture prevention from osteoporosis to falls.

Authors:  Teppo L N Järvinen; Harri Sievänen; Karim M Khan; Ari Heinonen; Pekka Kannus
Journal:  BMJ       Date:  2008-01-19

Review 5.  Management of osteoporosis in geriatric populations.

Authors:  Diane L Schneider
Journal:  Curr Osteoporos Rep       Date:  2008-09       Impact factor: 5.096

6.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

Review 7.  A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents.

Authors:  Anna M Sawka; Nofisat Ismaila; Ann Cranney; Lehana Thabane; Monika Kastner; Amiram Gafni; Linda J Woodhouse; Richard Crilly; Angela M Cheung; Jonathan D Adachi; Robert G Josse; Alexandra Papaioannou
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

Review 8.  Diagnosis and management of osteoporosis in the older senior.

Authors:  Sheryl F Vondracek; Sunny A Linnebur
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

Review 9.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; N Burlet; C Cooper; P D Delmas; J-Y Reginster; F Borgstrom; R Rizzoli
Journal:  Osteoporos Int       Date:  2008-02-12       Impact factor: 4.507

10.  Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture.

Authors:  Roland D Chapurlat
Journal:  Ther Clin Risk Manag       Date:  2009-05-04       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.